Rating History for Crescent Biopharma Inc (CBIO) by Guggenheim

More Stocks Rated by Guggenheim | Latest Ratings for CBIO
Date Analyst Type Rating
(Past)		 PT
(Past)		 Start $
(End $)		 % Chg. Details
1/21/2026 Brad Canino New Coverage Buy
(N/A)		 35.00
(N/A)		 13.98
(17.34)		 24.03% Details